SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting

NCT ID: NCT02290262

Last Updated: 2017-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

326 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Patients undergoing coronary artery bypass graft surgery often experience a range of problems and symptoms related to the procedure and the underlying heart disease.These problems include anxiety and depressive symptoms, immobility issues, complications such as wound seeping, neck and shoulder pains, interrupted and insufficient sleep. No studies have tested a combined intervention on phase 1 rehabilitation in coronary artery bypass graft surgery patients. However, randomised trials with either a physical or a mental part have been conducted with positive result, but evidence is lacking for a combined intervention. Before a large randomised trial was set up a pilot trial was conducted to evaluate the feasibility of patient recruitment and intervention: to test the safety and tolerability of the intervention by patients and to provide outcome data for sample size calculations. The SheppHeartCABG pilot showed trial feasibility, safety and sufficient inclusion rate and high compliance with most elements. Outcome data from the pilot trial has been used to sample size and power calculation in this randomised clinical trial.

Objective: The objective of this trial is to investigate the benefits and harms of a phase 1 comprehensive cardiac rehabilitation programme consisting of an exercise-training and a psycho-educative component, including plus treatment as usual in patients who undergo coronary artery bypass grafting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Patients undergoing coronary artery bypass grafting surgery often experience a range of problems and symptoms related to the procedure and the underlying heart disease. These problems include anxiety and depressive symptoms, immobility issues, complications such as wound seeping, neck and shoulder pains, interrupted and insufficient sleep. Over the last 2 decades, cardiac rehabilitation has become recognized as a significant component in the continuum of care for persons with cardiovascular disease. Furthermore, cardiac rehabilitation has undergone a significant evolution moving from a focused exercise intervention to a comprehensive disease management program. In Guidelines for Coronary Artery Bypass Graft Surgery cardiac rehabilitation is described as including early ambulation during hospitalisation and outpatient prescriptive exercise training beginning 6-8 weeks following surgery. Our hypothesis is that a comprehensive rehabilitation programme including physical exercise with moderate intensity and a psycho-educative component can begin in the early postoperative phase during hospitalising.

No studies have tested a combined intervention on phase 1 rehabilitation in coronary artery bypass graft surgery patients. However, randomised trials with either a physical or a mental part have been conducted with positive result, but evidence is lacking for a combined intervention. Before a large randomised trial was set up a pilot trial was conducted to evaluate the feasibility of patient recruitment and intervention: to test the safety and tolerability of the intervention by patients and to provide outcome data for sample size calculations. The SheppHeartCABG pilot showed trial feasibility, safety and sufficient inclusion rate and high compliance with most elements. Outcome data from the pilot trial has been used to sample size and power calculation in this randomised clinical trial.

Objective: The objective of this trial is to investigate the benefits and harms of a phase 1 comprehensive cardiac rehabilitation programme consisting of an exercise-training and a psycho-educative component, including plus treatment as usual in patients who undergo coronary artery bypass grafting.

Design: SheppHeartCABG is an investigator-initiated randomised clinical trial with 1:1 randomisation from two sites to a comprehensive physical and psycho-educative rehabilitation programme plus usual care or usual care alone, with blinded outcome assessment.

Population: Patients 18 years or older with ischaemic heart disease, who have to undergo elective coronary artery bypass grafting, who speak and understand Danish and who provide a written informed consent will be included. The following patients will be excluded from the trial: patients at intermediate or high risk to their cardiovascular status according to guidelines, patients with neurological or orthopaedic deficits which prevent training and patients who do not wish to participate.

Number of participants: 326 participants will be included.

Interventions: All patients - both in the intervention group and in the control group - receive usual care. Patients allocated to the experimental group receive a rehabilitation programme consisting of physical exercise and psycho-education. The control group will receive usual care alone. The physical exercises consist of; breathing exercises with and without using incentive spirometry with expiratory positive pressure airway, walking and cycling exercises and neck/shoulder exercises during hospitalisation and an exercise programme running from discharge until 4 weeks following surgery. The psycho-educative rehabilitation programme consists of four psycho-educative consultations with a specially trained nurse. The last consultation will take place 4 weeks following surgery.

Outcomes: Primary outcome is physical capacity measured by 6-minute walk test 4 weeks following surgery. Secondary outcomes; perceived mental and physical(SF 12), health-related quality of life (HeartQoL), anxiety and depression (HADS), sleep (PSQI), pain (ÖMPSQ) and leg endurance and strength (sit and stand test). Explorative outcomes are; fatigue (MFI-20), physical activity (IPAQ), cognitive and emotional representation of illness (B-IPQ) and self-rated health (EQ-5D).

Safety: There are no previous reports of risks associated with psycho-educational consultations. Physical exercise is tested extensively in patients with heart disease and is considered safe and will meet the applicable requirements for safety during training of cardiac patients. The interventions are considered safe for patients at low risk according to their cardiovascular status.

Ethical considerations: The trial is performed in accordance with the Declaration of Helsinki in its latest form. All patients must give informed consent prior to participation and the trial is initiated after approval by the Danish Data Protection Agency and the regional ethics committee. The trial will be registered at www.clinicalTrials.gov before randomisation of the first participant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ischaemic Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Comprehensive phase one rehabilitation

Patients allocated to the experimental group receive a rehabilitation programme consisting of physical exercise and psycho-education plus usual care.

Group Type EXPERIMENTAL

Comprehensive phase one rehabilitation

Intervention Type OTHER

Patients allocated to the experimental group receive a rehabilitation programme consisting of physical exercise and psycho-education.

The physical exercises consist of; breathing exercises with and without using incentive spirometry with expiratory positive pressure airway, walking and cycling exercises and neck/shoulder exercises during hospitalisation and an exercise programme running from discharge until 4 weeks following surgery. The psycho-educative rehabilitation programme consists of four psycho-educative consultations with a specially trained nurse.

Usual care

The control group will receive usual care alone.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Comprehensive phase one rehabilitation

Patients allocated to the experimental group receive a rehabilitation programme consisting of physical exercise and psycho-education.

The physical exercises consist of; breathing exercises with and without using incentive spirometry with expiratory positive pressure airway, walking and cycling exercises and neck/shoulder exercises during hospitalisation and an exercise programme running from discharge until 4 weeks following surgery. The psycho-educative rehabilitation programme consists of four psycho-educative consultations with a specially trained nurse.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18 years or older with ischaemic heart disease,
* Who have to undergo elective coronary artery bypass grafting,
* Who speak and understand Danish and
* Who provide a written informed consent will be included.

Exclusion Criteria

Patients will be excluded from the trial:

* Patients at intermediate or high risk to their cardiovascular status according to guidelines,
* Patients with neurological or orthopaedic deficits which prevent training and
* Patients who do not wish to participate.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Odense University Hospital

OTHER

Sponsor Role collaborator

Rigshospitalet, Denmark

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Selina Kikkenborg Berg

Senior researcher

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Selina Berg, PhD

Role: PRINCIPAL_INVESTIGATOR

Rigshospitalet, Denmark

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hjertecentret, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9

Copenhagen, OE, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Hojskov IE, Moons P, Hansen NV, La Cour S, Olsen PS, Gluud C, Winkel P, Lindschou J, Thygesen LC, Egerod I, Berg SK. SheppHeartCABG trial-comprehensive early rehabilitation after coronary artery bypass grafting: a protocol for a randomised clinical trial. BMJ Open. 2017 Jan 17;7(1):e013038. doi: 10.1136/bmjopen-2016-013038.

Reference Type DERIVED
PMID: 28096255 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SheppHeartCABG RCT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.